• Mon, May 15, 2023

Leland Gershell Reiterated (URGN) at Buy and Held Target at $22 on, May 15th, 2023

Leland Gershell of Oppenheimer, Reiterated "UroGen Pharma Ltd." (URGN) at Buy and Held Target at $22 on, May 15th, 2023.

Leland has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, all agrees with Leland's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $10 on, Wednesday, February 8th, 2023